epigenoma de la leucemia linfática crónica
Published 11 years ago • 4.6K plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
2:12
complete epigenome of cll reveals important areas of dysregulation
-
1:35
shifting the focus in cll: the epigenome
-
6:23
epigenetic aging and neurocognitive function in hodgkin lymphoma survivors
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:41
dr. dinardo on the rationale for the pooled analysis evaluating venetoclax in aml
-
3:05
zuma-1, juliet and transcend trials: changing the treatment landscape for r/r nhl
-
21:14
alberto magi: exploring the genomic & epigenomic landscape of acute myeloid leukemia
-
9:13
treating acute leukaemias of ambiguous lineage
-
4:15
phase ib/ii trial of quizartinib, decitabine and venetoclax in flt3-itd-mutated aml
-
5:22
chronic lymphoblastic leukemia
-
2:51
novel agent filanesib combination therapy for r/r multiple myeloma
-
56:36
the end of dicer1
-
4:38
novel combinations being explored in aml using an hma-venetoclax backbone
-
27:36
novel therapies in myeloid neoplasms
-
2:17
outcomes of patients with monocytic aml treated with venetoclax & azacitidine
-
2:16
the challenges in producing efficacious i-o products for aml
-
1:36
dr. d’amato on the emerging role of next-generation sequencing in sarcoma
-
3:08
paolo caimi, md | cleveland clinic hematología y oncología (spanish)
-
2:24
the latest clinical trials into novel aml therapies